Stuart A. Scott
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
-
- Pharmaceutical studies and practices
Papers in
- Pharmacology 79
- Pharmacogenetics and Drug Metabolism 79
- Genetics 51
- Genomics and Rare Diseases 34
- Genomic variations and chromosomal abnormalities 13
- BRCA gene mutations in cancer 10
- Co-authors
- Teri E. Klein (21 shared papers)Katrin Sangkuhl (10 shared papers)Michelle Whirl‐Carrillo (19 shared papers)Robert J. Desnick (21 shared papers)Andrea Gaedigk (20 shared papers)Catherine Stein (3 shared papers)Victoria M. Pratt (21 shared papers)Ruth Kornreich (14 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (32 papers)Journal of Molecular Diagnostics (17 papers)Pharmacogenomics (12 papers)Genetics in Medicine (8 papers)Clinical and Translational Science (6 papers)
- Partner nations
- United StatesPuerto RicoJapan
In The Last Decade
Stuart A. Scott
169 papers receiving 12.3k citations
Stuart A. Scott's Hit Papers
Peers
Comparison fields: 5 of 146
- Pharmacology 5.6k
- Pediatrics, Perinatology and Child Health 1.9k
- Cardiology and Cardiovascular Medicine 2.1k
- Genetics 2.0k
- Statistics and Probability 627
Countries citing papers authored by Stuart A. Scott
This map shows the geographic impact of Stuart A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Scott more than expected).
Fields of papers citing papers by Stuart A. Scott
This network shows the impact of papers produced by Stuart A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Scott. The network helps show where Stuart A. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart A. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update Hit paper breakdown → | 2013 | 777 |
| 2 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 769 |
| 3 | Multi-ethnic genome-wide association study for atrial fibrillation Hit paper breakdown → | 2018 | 559 |
| 4 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Hit paper breakdown → | 2011 | 535 |
| 5 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update Hit paper breakdown → | 2017 | 519 |
| 6 | Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group Hit paper breakdown → | 2019 | 417 |
| 7 | Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) Hit paper breakdown → | 2016 | 415 |
| 8 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy Hit paper breakdown → | 2011 | 407 |
| 9 | Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process Hit paper breakdown → | 2014 | 356 |
| 10 | Medical Genetics Summaries | 2012 | 334 |
| 11 | 2016 | 313 | |
| 12 | 2017 | 266 | |
| 13 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 , CYP2C19 , CYP2B6 , SLC6A4 , and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants Hit paper breakdown → | 2023 | 253 |
| 14 | 1995 | 248 | |
| 15 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing Hit paper breakdown → | 2020 | 230 |
| 16 | 2013 | 216 | |
| 17 | 2014 | 202 | |
| 18 | 2018 | 171 | |
| 19 | 2011 | 168 | |
| 20 | 2011 | 167 |
About Stuart A. Scott
Stuart A. Scott is a scholar working on Pharmacology, Genetics, Pediatrics, Perinatology and Child Health, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 174 papers that have together received 12.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (79 papers), Genomics and Rare Diseases (34 papers), Pharmaceutical studies and practices (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers), Genomic variations and chromosomal abnormalities (13 papers), Statistical Methods in Clinical Trials (11 papers), Drug Transport and Resistance Mechanisms (11 papers) and BRCA gene mutations in cancer (10 papers). The work is most often cited by research in Pharmacology (5.6k citations), Pediatrics, Perinatology and Child Health (1.9k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Genetics (2.0k citations) and Statistics and Probability (627 citations). Stuart A. Scott has collaborated with scholars based in United States, Puerto Rico and Japan. Frequent co-authors include Teri E. Klein, Katrin Sangkuhl, Michelle Whirl‐Carrillo, Robert J. Desnick, Andrea Gaedigk, Catherine Stein, Victoria M. Pratt, Ruth Kornreich, Dan M. Roden and Alan R. Shuldiner. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Molecular Diagnostics, Pharmacogenomics, Genetics in Medicine and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.